In this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco. 

We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", why R&D productivity is the mental model for managing R&D at scale, practical advice on how to approach and work with R&D productivity, and much more!

If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast

If you prefer to watch the episode as a video, you can also get the podcast from YouTube, just search for "Cures & Capital".

If you want to connect with Aaron or read about BiomEdit:
Linkedin: https://www.linkedin.com/in/aaronlschacht/
BiomEdit: https://www.biomedit.com

Research paper: "How to improve R&D productivity: the pharmaceutical industry's grand challenge"
Link: https://www.nature.com/articles/nrd3078

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.